If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019
Open Access

Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: A case report

Bellia, S. R., Feliciani, G., Del Duca, M., Monti, M., Turri, V., Sarnelli, A., Romeo, A., Kelson, I., Keisari, Y., Popovtzer, A., Ibrahim, T., Paganelli, G. & Stanganelli, I., Jan 1 2019, In : Journal of Contemporary Brachytherapy. 11, 5, p. 449-457 9 p.

Research output: Contribution to journalArticle

Open Access
Open Access

Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

PITER Collaborating group available at www.progettopiter.it, Feb 13 2019, In : PharmacoEconomics. 37, 2, p. 255-266 12 p.

Research output: Contribution to journalArticle

2018

New requirements for phase i trials: A challenge for I talian clinical research

Marchesi, E., Monti, M., Nanni, O., Bassi, L., Piccinni-Leopardi, M. & Cagnazzo, C., 2018, In : Tumori. 104, 1, p. 15-21 7 p.

Research output: Contribution to journalArticle

Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

Karampatou, A., Han, X., Kondili, L. A., Taliani, G., Ciancio, A., Morisco, F., Critelli, R. M., Baraldi, E., Bernabucci, V., Troshina, G., Guarino, M., Tagliavini, S., D'Ambrosio, F., Bristot, L., Turco, L., Rosato, S., Vella, S., Trenti, T., Neri, I., La Marca, A. & 31 others, Manthena, S., Goldstein, A. S., Bruno, S., Bao, Y., Gonzalez, Y. S., Villa, E., Craxì, A., Petta, S., Calvaruso, V., Brunetto, M., Coco, B., Chessa, L., Pasetto, M. C., Bigliotti, E., Tamburrini, F., Montalto, G., Monti, M., Finati, E., Milella, M., Russo, F. P., Gemma, M., Gori, A., Bruno, R., Cima, S., Coppola, C., Simonetti, G., Brancaccio, G., Mondelli, M., Ludovisi, S., Persico, M. & PITER framework investigators, Jan 1 2018, In : Journal of Hepatology. 68, 1, p. 33-41 9 p.

Research output: Contribution to journalArticle

2017

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J-Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 8 others, Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P., Casali, P. G. & Monti, M., 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

New requirements for phase I trials: a challenge for Italian clinical research.

Marchesi, E., Monti, M., Nanni, O., Bassi, L., Piccinni Leopardi, M. & Cagnazzo, C., 2017, In : Tumori.

Research output: Contribution to journalArticle

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

Rocca, A., Cecconetto, L., Passardi, A., Melegari, E., Andreis, D., Monti, M., Maltoni, R., Sarti, S., Pietri, E., Schirone, A., Fabbri, F., Donati, C., Nanni, O., Fedeli, A., Faedi, M. & Amadori, D., May 1 2017, In : Cancer Chemotherapy and Pharmacology. 79, 5, p. 863-871 9 p.

Research output: Contribution to journalArticle

Predictors of mortality in nursing-home residents with pneumonia: A multicentre study

Falcone, M., Russo, A., Gentiloni Silverj, F., Marzorati, D., Bagarolo, R., Monti, M., Velleca, R., D'Angelo, R., Frustaglia, A., Zuccarelli, G. C., Prina, R., Vignati, M., Marnati, M. G., Venditti, M. & Tinelli, M., Jun 2017, In : Clinical Microbiology and Infection.

Research output: Contribution to journalArticle

2016

Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Sansovini, M., Severi, S., Ianniello, A., Nicolini, S., Fantini, L., Mezzenga, E., Ferroni, F., Scarpi, E., Monti, M., Bongiovanni, A., Cingarlini, S., Grana, C. M., Bodei, L. & Paganelli, G., Nov 2 2016, (Accepted/In press) In : European Journal of Nuclear Medicine and Molecular Imaging. p. 1 1 p.

Research output: Contribution to journalArticle

Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Sansovini, M., Severi, S., Ianniello, A., Nicolini, S., Fantini, L., Mezzenga, E., Ferroni, F., Scarpi, E., Monti, M., Bongiovanni, A., Cingarlini, S., Grana, C. M., Bodei, L. & Paganelli, G., Nov 2 2016, (Accepted/In press) In : European Journal of Pediatrics. p. 1 1 p.

Research output: Contribution to journalArticle

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Sansovini, M., Severi, S., Ianniello, A., Nicolini, S., Fantini, L., Mezzenga, E., Ferroni, F., Scarpi, E., Monti, M., Bongiovanni, A., Cingarlini, S., Grana, C. M., Bodei, L. & Paganelli, G., Oct 4 2016, (Accepted/In press) In : European Journal of Nuclear Medicine and Molecular Imaging. p. 1-10 10 p.

Research output: Contribution to journalArticle

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Sansovini, M., Severi, S., Ianniello, A., Nicolini, S., Fantini, L., Mezzenga, E., Ferroni, F., Scarpi, E., Monti, M., Bongiovanni, A., Cingarlini, S., Grana, C. M., Bodei, L. & Paganelli, G., Oct 4 2016, (Accepted/In press) In : European Journal of Pediatrics. p. 1-10 10 p.

Research output: Contribution to journalArticle

2015

111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: Its accuracy and prognostic significance

Genestreti, G., Bongiovanni, A., Burgio, M. A., Burgio, S. L., Musto, A., Rossi, A., Monti, M., Scarpi, E., Ulivi, P., Bravaccini, S., Dubini, A., Matteucci, F. & Gavelli, G., Feb 3 2015, In : Nuclear Medicine Communications. 36, 2, p. 135-142 8 p.

Research output: Contribution to journalArticle

Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC

Severi, S., Sansovini, M., Ianniello, A., Bodei, L., Nicolini, S., Ibrahim, T., Di Iorio, V., D’Errico, V., Caroli, P., Monti, M. & Paganelli, G., Jun 26 2015, In : European Journal of Nuclear Medicine and Molecular Imaging. 42, 13, p. 1955-1963 9 p.

Research output: Contribution to journalArticle

Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET

Ianniello, A., Sansovini, M., Severi, S., Nicolini, S., Grana, C. M., Massri, K., Bongiovanni, A., Antonuzzo, L., Di Iorio, V., Sarnelli, A., Caroli, P., Monti, M., Scarpi, E. & Paganelli, G., Nov 27 2015, (Accepted/In press) In : European Journal Of Nuclear Medicine. p. 1-7 7 p.

Research output: Contribution to journalArticle

2014

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

Paganelli, G., Sansovini, M., Ambrosetti, A., Severi, S., Monti, M., Scarpi, E., Donati, C., Ianniello, A., Matteucci, F. & Amadori, D., Oct 1 2014, In : European Journal of Nuclear Medicine and Molecular Imaging. 41, 10, p. 1845-1851 7 p.

Research output: Contribution to journalArticle

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: A suitable regimen and review of the literature

Bongiovanni, A., Riva, N., Calpona, S., Ricci, M., Gunelli, E., Liverani, C., La Manna, F., De Vita, A., Monti, M., Severi, S., Pieri, F., Amadori, E., Galassi, R., Cavaliere, D., Zaccaroni, A., Tartaglia, A., Lunedei, V., Gardini, A., Mercatali, L., Amadori, D. & 1 others, Ibrahim, T., Oct 20 2014, In : OncoTargets and Therapy. 7, p. 1919-1926 8 p.

Research output: Contribution to journalArticle

2013

Erratum: Multicenter Institutional Experience of Surgically Resected Thymic Epithelial Tumors (TETs): An Observational Report on Behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone) (Ann Surg Oncol DOI: 10.1245/S10434-013-3018-2)

Genestreti, G., Ampollini, L., Burgio, M. A., Rolli, L., Sanna, S., Scarpi, E., Monti, M., Burgio, S. L., Giannone, L., Santo, A., Mezzetti, M., Casanova, C., Buosi, R., Rusca, M., Amadori, D. & Gavelli, G., 2013, In : Annals of Surgical Oncology. 20, 3 SUPPL.

Research output: Contribution to journalArticle

Multicenter institutional experience of surgically resected thymic epithelial tumors (TETs): An observational report on behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone)

Genestreti, G., Ampollini, L., Burgio, M. A., Rolli, L., Sanna, S., Scarpi, E., Monti, M., Salvatore, L. B., Giannone, L., Santo, A., Mezzetti, M., Casanova, C., Buosi, R., Rusca, M., Amadori, D. & Gavelli, G., Sep 2013, In : Annals of Surgical Oncology. 20, 9, p. 2958-2963 6 p.

Research output: Contribution to journalArticle

Treatment with the radiolabelled somatostatin analog Lu-DOTATATE for advanced pancreatic neuroendocrine tumors

Sansovini, M., Severi, S., Ambrosetti, A., Monti, M., Nanni, O., Sarnelli, A., Bodei, L., Garaboldi, L., Bartolomei, M. & Paganelli, G., Jun 2013, In : Neuroendocrinology. 97, 4, p. 347-354 8 p.

Research output: Contribution to journalArticle

2005

Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: A phase I study

Ibrahim, T., Zoli, W., Frassineti, G. L., Tesei, A., Colantonio, I., Monti, M. & Amadori, D., Feb 2005, In : Lung Cancer. 47, 2, p. 261-267 7 p.

Research output: Contribution to journalArticle

2003

Doxorubicin, Paclitaxel and Gemcitabine: A Phase I Study of a New Sequential Treatment in Stage III B - IV Breast Cancer

Ibrahim, T., Fabbri, M., Frassineti, G. L., Zoli, W., Monti, M., Ricotti, L. & Amadori, D., Oct 2003, In : Journal of Chemotherapy. 15, 5, p. 488-494 7 p.

Research output: Contribution to journalArticle

2002

Docetaxel followed by gemcitabine in the treatment of advanced non-small cell lung cancer: A phase I study

Frassineti, G. L., Ibrahim, T., Zoli, W., Monti, M., Ricotti, L., Nanni, O. & Amadori, D., 2002, In : Tumori. 88, 2, p. 99-103 5 p.

Research output: Contribution to journalArticle